Quantcast Pharmaceutical Industry News - Congoo
 
 
Log In
  INDUSTRY >> PHARMACEUTICAL INDUSTRY    Get our Pharmaceutical Industry daily Briefing     
Accounting
Advertising & marketing
Advertising industry
Aerospace & defense
Agriculture
Airline industry
Automotive industry
Banking
beverage related
Biological sciences
Biotech
Book publishing
Broadcasting industry
Business
Cable industry
Cancer
Charities
Chemicals industry
Climate change
Clothing industry
Coal industry
Commodities
Communications equipment
Computer games
Computer security
Computer services
Construction
Corporate finance
Corporate governance
Crime & Punishment
CRM
Database industry
Derivatives
Developer
Digital television
Drinks & beverage industry
Durable goods
E-commerce
Economics
Electronics
Emerging markets
Energy
Engineering Industry
Enterprise computing
Entrepreneur
Environment
Equity markets
Fashion
Fed watch
Finance related
Firearms industry
Fitness
Food and drink
Food industry
Forex markets
Fund management
Gaming
Genetics
government: general
Graphics industry
Handhelds
Healthcare
Horse racing
Hospitality industry
Human resources
Human rights
Human sciences
Imaging equipment
Insurance industry
International development
International Paper Company
International relations
Internet news
IP and patents
IPO
Java
Job markets
Journalism
Knowledge management
Law
Leisure goods
Linux
Logistics
Management
Manufacturing
Marketing
Media
Medical
Mergers & acquisitions
Metals industry
Mining and metals
Mobile industry
Mortgage industry
Movie business
Music business
Mutual funds
Nanotechnology
Newspaper publishing
Oil & gas
Online access
Online broker
Online content
Online information
Online marketing
Online portals
Open source
OS news
Outdoor recreation
Outsourcing
Packaging & paper
Paper
PC industry
PC software
Personal data privacy
Personal finance
Personal technology
Pharmaceutical Industry
Physical Sciences
Plastics industry
Police
Pop music
Public health
Real Estate industry
Recreation
Religion
Retail investor
Retail sector
RFID
Robotics
RSS
Science
Search Engines
Securities industry
Semiconductor industry
Shipping industry
Silicon Valley
Small business
Space science
Steelmaking
Tech stocks
Technology
Telecom industry
television: general
Textiles
Tobacco industry
Trade
Transportation industry
Travel & Vacation
Travel industry
US banking
US immigration
US politics
US security
US social policy
Utilities News
Venture Capital
Web developer
Wireless sector
XML & metadata
 
 



Avid Bioservices to Make Three Presentations at IBC's Biopharmaceutical Development   - 3/31/2015
ys to Achieve and Monitor Manufacturing Consistency Optimizing Purification Techniques to Remove Process-Related Impurities With No Impact on Critical Quality Attributes; Strategies for Developing
all 1 news articles >>
  
    



Dyax Corp announces positive results from phase 1b clinical trial of DX-2930   - 3/31/2015
9:01pm BST   Dyax Corp:Says positive safety, pharmacokinetic, biomarker, and efficacy results from the Phase 1b clinical study of their investigational product, DX-2930.Discovered by Dyax, DX-2930 is
  
    




Immune Design announces positive topline data from three phase 1 CLINICAL TRIALS   - 3/31/2015
9:10pm BST   Immune Design:Reported that analyses of data from three ongoing Phase 1 studies support continued development of its two primary product candidates, CMB305 and G100.CMB305 and G100 represent
  
    



ESSA Pharma Inc announces filing of investigational new drug application for EPI-506   - 3/31/2015
8:01pm BST   ESSA Pharma Inc:Says it has filed with Food and Drug Administration in the US an investigation new drug application related to proposed clinical trial of EPI-506 in prostate cancer patients.Says
  
    



Aphria Retracts Previously Issued Statement   - 3/31/2015
LEAMINGTON, ONTARIO -- (Marketwired) -- 03/31/15 -- Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE: APH) retracts the statement made in its press release dated March 25, 2015, wherein the Company
all 1 news articles >>
  
    



What '60 Minutes' Say On New Cancer Treatment   - 3/31/2015
Last night, CBS’ hit newsmagazine 60 Minutes devoted not one but two segments to an early-stage trial at Duke University of a cancer therapy that some patients are calling a “miracle.” It’s a genetically
  
    


Your sponsored post can go right here! Sponsored

Congoo’s B2B information portal now receives over 1 million visits per month.  Congoo provides a highly influential audience comprehensive news and information within their industry.  Reach a coveted audience of senior executives, affluent males and opinion leaders. Get the Media Kit




Your Brain Detects Vocal Confidence Faster Than A Blink   - 3/31/2015
Business management and sales training often includes sessions on how to say what you want to say – the tone-of-voice packaging of the message. This is partly intuitive — the pitch and weight of one’s
  
    



What Everyone Should Learn From PBS' Cancer Doc   - 3/31/2015
No surprise: PBS’ “Cancer: The Emperor of All Maladies” is exactly the documentary one wishes every person who has ever been captivated by a breathless news report about cancer research would watch first.
all 1 news articles >>
  
    



Dicerna Pharmaceuticals, Inc. Reports Inducement Grants Under NASDAQ Listing Rule   - 3/31/2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNA interference-based therapeutics targeting rare inherited diseases involving the liver
  
    


Reach your target audience with AdBlade! Sponsored
- Brand your product
- Create awareness in your product
- Drive traffic

And do it all on a CPC basis of as little as 50 cents.  Try AdBlade and begin reaching your targ.  Learn More



2015 BIO International Convention Super Sessions Announced   - 3/31/2015
Topics Include: Patient Access, Antimicrobial Resistance and Deal-Making Trends WASHINGTON--(BUSINESS WIRE)-- The 2015 BIO International Convention ® will feature Super Sessions focusing on
  
    



Study: Cancer drug found to restore memory in mice holds promise as Alzheimer’s   - 3/31/2015
A drug originally designed to target cancer has been found to restore memory and reverse cognitive problems in mice with Alzheimer’s disease-like symptoms and could offer a path forward to a treatment
  
    



Adamas Pharmaceuticals Issued Patent   - 3/31/2015
(GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that United States Patent and Trademark Office (USPTO) issued US Patent No. 8,987,333 entitled "Composition and Method for
  
    


American Express takes you places Sponsored
The Preferred Rewards Gold Card takes you places. And shows you’ve arrived. Enjoy Gold Card benefits and access while you earn travel rewards fast. Earn 10,000 Membership Rewards® bonus points redeemable for rewards after your first purchase.  Learn More



Novavax Announces Closing of Public Offering   - 3/31/2015
(GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today
all 10 news articles >>
  
    



Hi-Tech Pharmaceuticals Announces Fastin Rapid Release® Clinical Study Results   - 3/31/2015
/PRNewswire/ -- Fastin Rapid Release™ is a quantum leap in the field of weight loss backed by two clinical studies -- one showed an increase in the metabolism by 22% in 45 minutes*, and the second study
all 5 news articles >>
  
    



Federal Home Loan Bank of Atlanta Announces 2015 AHP Competitive Offering   - 3/31/2015
(GLOBE NEWSWIRE) -- Federal Home Loan Bank of Atlanta (FHLBank Atlanta) announced today that its 2015 Affordable Housing Program (AHP) Competitive Round will open on June 1. Up to $500,000 will be awarded
  
    



Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection   - 3/31/2015
/PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, is pleased to announce the addition of its newest plasma collection center located
  
    



Can-Fite plummets after psoriasis trial fails [Globes, Tel Aviv, Israel]   - 3/31/2015
March 31--The share price of Can-Fite BioPharma Ltd. (TASE:CFBI) plummeted yesterday after the company announced that its Phase II/III psoriasis trial for its drug candidate CF101 did not achieve its
all 1 news articles >>
  
    



UBS applauds Teva for Auspex acquisition [Globes, Tel Aviv, Israel]   - 3/31/2015
March 31--Analyst Marc Goodman of UBS has come out in praise of the deal whereby Teva Pharmaceutical Industries Ltd "The key asset is SD-809, which is in Phase 3 for Huntington's disease, Phase 2/3
all 1 news articles >>
  
    



ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506   - 3/31/2015
/PRNewswire/ - ESSA Pharma Inc The IND application is a complete description of the chemistry, non-clinical pharmacodynamics and pharmacokinetics, animal toxicology, manufacturing, and other relevant
  
    



Nymox Reports 2014 Financial Results   - 3/31/2015
(GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today its financial results for the year ended December 31, 2014 prepared in accordance with International Financial Reporting
all 1 news articles >>
  
    



New McPherson CCD-UV Absorbance Spectrophotometer extends capabilities to deep ultraviolet   - 3/31/2015
/PRNewswire/ -- Fast DUV Spectrophotometer McPherson's newest VUVAS spectrophotometer capitalizes on the speed and sensitivity of direct detection, ultraviolet sensitive CCD detectors. Faster data
all 1 news articles >>
  
    



Vaccinex Provides an Update on Its VX15/2503 Phase 1 Clinical Trial in Multiple   - 3/31/2015
(GLOBE NEWSWIRE) -- Vaccinex, Inc. today announced the successful completion of a multicenter phase 1, randomized, double-blind, placebo-controlled, single ascending-dose safety and tolerability study
all 1 news articles >>
  
    



SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of SanDisk Corporation   - 3/31/2015
(GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of SanDisk Corporation (Nasdaq:SNDK)
all 6 news articles >>
  
    



Peregrine Pharmaceuticals Announces Promising Bavituximab Phase I Data Published   - 3/31/2015
- Combination of Bavituximab and Paclitaxel Achieved an 85% Objective Response- - Design of Phase II Clinical Trial Underway - TUSTIN, Calif., March 31, 2015 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals
all 1 news articles >>
  
    



Aegis Sciences Corporation Announces Play Again Now(TM) Is Aegis Shield CERTIFIED(R)   - 3/31/2015
NASHVILLE, TN--(Marketwired - Mar 31, 2015) -  Aegis Sciences Corporation is pleased to announce that Play Again Now™ by Viscos, LLC has met the standards of the Aegis Shield CERTIFIED supplement certification
  
    
*Votes may take up to 30 minutes to influence article rank order


Featured Members
Larry Vaughn Larry Vaughn
Sr. Partner
Pharma Industry
Shannon Peryea Shannon Peryea
Vice President, Executive Recruiting
Pharma Industry
Frank Forney Frank Forney
Pharma Industry
George Green George Green
Sales Counselor
Pharma Industry

  Add your Profile
  View more profiles

   




 
 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2015 Congoo.com. All Rights Reserved.